The HyperPed-COVID international registry: Impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C

. 2024 Jul ; 147 () : 103265. [epub] 20240604

Jazyk angličtina Země Velká Británie, Anglie Médium print-electronic

Typ dokumentu časopisecké články, multicentrická studie

Perzistentní odkaz   https://www.medvik.cz/link/pmid38838452
Odkazy

PubMed 38838452
DOI 10.1016/j.jaut.2024.103265
PII: S0896-8411(24)00099-4
Knihovny.cz E-zdroje

OBJECTIVES: The aim of the study was to establish an international multicenter registry to collect data on patients with Multisystem Inflammatory Syndrome in Children (MIS-C), in order to highlight a relationship between clinical presentation, age of onset and geographical distribution on the clinical outcome. STUDY DESIGN: Multicenter retrospective study involving different international societies for rare immunological disorders.1009 patients diagnosed with MIS-C between March and September 2022, from 48 centers and 22 countries were collected. Five age groups (<1, 1-4, 5-11, 12-16, >16 years) and four geographic macro-areas, Western Europe, Central-Eastern Europe, Latin America, Asian-African resource-limited countries (LRC), were identified. RESULTS: Time to referral was significantly higher in LRC. Intensive anti-inflammatory treatment, including biologics, respiratory support and mechanic ventilation were more frequently used in older children and in European countries. The mortality rate was higher in very young children (<1 year), in older patients (>16 years of age) and in LRC. Multivariate analysis identified the residence in LRC, presence of severe cardiac involvement, renal hypertension, lymphopenia and non-use of heparin prophylaxis, as the factors most strongly associated with unfavorable outcomes. CONCLUSIONS: The stratification of patients by age and geographic macro-area provided insights into the clinical presentation, treatment and outcome of MIS-C. The mortality and sequelae rates exhibited a correlation with the age and geographical areas. Patients admitted and treated in LRC displayed more severe outcomes, possibly due to delays in hospital admission and limited access to biologic drugs and to intensive care facilities.

1 Horbachevsky Ternopil National Medical University Department of Children's Diseases and Pediatric Surgery Ternopil Ukraine

Amruta Hospital Pediatrics Rajkot India

ASST Papa Giovanni XXIII Bergamo Italy

AZ Delta Rumbeke Belgium

Bangabandhu Sheikh Mujib Medical Universit Dhaka Bangladesh

Bangabandhu Sheikh Mujib Medical University Paediatrics Dhaka Bangladesh

Cattolica Sacro Cuore University Roma Italy

České Budějovice Hospital Ceske Budejovice Czech Republic

Children Hospital G Di Cristina Palermo Italy

Children's Hospital Zagreb Department of Pulmonology Allergology Clinical Immunology and Rheumatology The University of Zagreb School of Medicine Zagreb Croatia

Children's Regional Clinical Hospital in Dnipro Dnipro Ukraine

Clinica Pediatrica Dell'Università di Brescia Spedali Civili Brescia Italy

Division of Immunology and Allergy Lausanne University Hospital and University of Lausanne Lausanne Switzerland

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Pediatria e Immunoreumatologia2 Milan Italy

General University Hospital and 1st Faculty of Medicine Charles University Prague Czech Republic

Gent University Hospital Gent Belgium

Gent University Hospital Pediatric Rheumatology Gent Belgium

Hacettepe University Children's Hospital Ankara Turkey

Hacettepe University Faculty of Medicine Department of Pediatrics Division of Pediatric Rheumatology Ankara Turkey

Health Sciences University Umraniye Training and Research Hospital Department of Pediatric Rheumatology Istanbul Turkey

Hospital Das Clínicas Botucatu Medicine University UNESP Botucatu Brazil

Hospital Infantil de México Federico Gómez Medicina Interna y Reumatologia Mexico City Mexico

Hospital Interzonal de Agudos Especializado en Pediatría Sor María Ludovica Sala de Reumatologia La Plata Argentina

Hospital México Americano Guadalajara Mexico

Hospital Parc Taulí de Sabadell Reumatologia Pediàtrica Servei de Medicina Pediàtrica Barcelona Spain

Hospital Santa Maria Lisbon Portugal

Hospital Sao Joao Porto Portugal

Hospital Universitario Dr J E Gonzalez Universidad Autónoma de Nuevo León Monterrey NL Mexico

Institute of Child and Maternal Health IRCCS Burlo Garofolo and University of Trieste Trieste Italy

IRCCS Istituto Giannina Gaslini Direzione Scientifica Genoa Italy

IRCCS Istituto Giannina Gaslini UOC Reumatologia e Malattie Autoinfiammatorie Genoa Italy

IRCCS Istituto Giannina Gaslini UOC Reumatologia e Malattie Autoinfiammatorie Genoa Italy; Università Degli Studi di Genova Dipartimento di Neuroscienze Riabilitazione Oftalmologia Genetica e Scienze Materno Infantili Genoa Italy

IRCCS Istituto Giannina Gaslini UOC Servizio di Sperimentazioni Cliniche Pediatriche PRINTO Genoa Italy

IRCCS Meyer Children's Hospital Rheumatology Unit ERN ReCONNECT Center Florence Italy

IRCCS Ospedale Pediatrico Bambino Gesù Division of Rheumatology Rome Italy

Mansoura University Children's Hospital Faculty of Medicine Mansoura University Mansura Egypt

Mansoura University Faculty of Medicine Mansoura Egypt

Mansoura University Mansoura Egypt

National Pirogov Memorial Medical University Vinnytsia Ukraine

Ospedale Pediatrico Giovanni XXIII Azienda Ospedaliero Universitaria Consorziale Policlinico Bari Italy

P a A Kyriakou Children's Hospital Athens Greece

Pediatrics Clinic University of Brescia and ASST Spedali Civili di Brescia Brescia Italy

Regina Margherita Children Hospital Immunology and Rheumatology Unit Turin Italy

Riga Stradins University Children University Hospital Riga Latvia

Rigshospitalet Copenhagen Denmark

Saint Petersburg State Pediatric Medical Academy Saint Petersburg Russian Federation

São Paulo State University Botucatu Brazil

State Institution Scientific Center of Children Health of Rams Moscow Moscow Russian Federation

Tajnsek University Children's Hospital University Medical Centre Ljubljana Ljubljana Slovenia

Ternopil Regional Children's Hospital Ternopil Ukraine

Thomayer University Hospital Prague Czech Republic

Translational Immunology Institute Singapore Singapore

UCL GOS Institute of Child Health London UK

Universidade Federal Do Rio de Janeiro Instituto de Puericultura e Pediatria Martagao Gesteira Rio de Janeiro Brazil

Universidade Federal Do Rio de Janeiro Rio de Janeiro Brazil

Universitiy Hospital Centre Split Split Croatia

University Children Hospital Department of Paediatric Rheumatology Sofia Bulgaria

University Children Hospital Riga Latvia

University Children Hospital Sofia Bulgaria

University Children's Hospital University Medical Center Ljubljana Department of Allergology Rheumatology and Clinical Immunology Ljubljana Slovenia

University Hospital Centre Split Department of Pediatrics Split Croatia

University Hospital Centre Zagreb University School of Medicine Zagreb Croatia

University Hospital Hradec Kralove Department of Pediatrics Hradec Kralove Czech Republic

University Hospital Hradec Kralove Hradec Kralove Czech Republic

University of Genoa Department of Health Sciences Genoa Italy

University of Nis Faculty of Medicine University Clinical Center Nis Clinic of Pediatrics Department of Pediatric Rheumatology Nis Serbia

UZ Leuven Universitair Ziekenhuis Leuven Belgium

UZ Leuven Universitair Ziekenhuis Leuven Belgium; KU Leuven University of Leuven Department of Microbiology and Immunology Laboratory Immunobiology Leuven Belgium

Varna Medical University Department of Pediatrics 1st Pediatric Clinic Varna Bulgaria

Western Ukrainian Specialized Children's Medical Centre Lviv Ukraine

Citace poskytuje Crossref.org

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...